相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Lucia Garcia-Gutierrez et al.
GENES (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
BET Proteins as Targets for Anticancer Treatment
Anastasios Stathis et al.
CANCER DISCOVERY (2018)
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition
Baoyuan Zhang et al.
ONCOGENE (2018)
Construction of a multiplex mutation hot spot PCR panel: the first step towards colorectal cancer genotyping on the GS Junior platform
Balint Peterfia et al.
JOURNAL OF CANCER (2017)
BET inhibitors: a novel epigenetic approach
D. B. Doroshow et al.
ANNALS OF ONCOLOGY (2017)
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
Pu Yan et al.
CLINICAL CANCER RESEARCH (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Sandy Amorim et al.
LANCET HAEMATOLOGY (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Structural determinants of Smad function in TGF-β signaling
Maria J. Macias et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Inactivation of MYC reverses tumorigenesis
Y. Li et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance
Peter S. Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer
Nicholas I. Fleming et al.
CANCER RESEARCH (2013)
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Sarah Picaud et al.
CANCER RESEARCH (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
A Correction to the Research Article Titled: "Inositol Polyphosphate Multikinase Is a Coactivator of p53-Mediated Transcription and Cell Death" by R. Xu, N. Sen, B. D. Paul, A. M. Snowman, F. Rao, M. S. Vandiver, J. Xu, S. H. Snyder
Science Signaling (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Panagiotis Papageorgis et al.
CANCER RESEARCH (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Jennifer A. Mertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Defective TGF-β signaling sensitizes human cancer cells to rapamycin
N. Gadir et al.
ONCOGENE (2008)
Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells
Hong Wang et al.
CANCER RESEARCH (2006)
Repression of Runx2 function by TGF-β through recruitment of class II histone deacetylases by Smad3
JS Kang et al.
EMBO JOURNAL (2005)
SMAD4 as a prognostic marker in colorectal cancer
H Alazzouzi et al.
CLINICAL CANCER RESEARCH (2005)
Transforming growth factor β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element
JP Frederick et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Role of Smad4 (DPC4) inactivation in human cancer
M Miyaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter
SQ Wu et al.
ONCOGENE (2003)
E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression
CR Chen et al.
CELL (2002)
Frequent loss of SMAD4/DPC4 protein in colorectal cancers
R Salovaara et al.
GUT (2002)
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway
KL Woodford-Richens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3
AL Gartel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Defective repression of c-myc in breast cancer cells:: A loss at the core of the transforming growth factor β growth arrest program
CR Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The transcriptional co-activator P/CAF potentiates TGF-β/Smad signaling
S Itoh et al.
NUCLEIC ACIDS RESEARCH (2000)
Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4
JB Jones et al.
NUCLEIC ACIDS RESEARCH (2000)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
分享论文
